{"schema_version":"secwatch.filing_event.v1","accession":"0001517022-26-000075","form_type":"8-K","ticker":"AKBA","cik":"0001517022","company_name":"Akebia Therapeutics, Inc.","filed_at":"2026-10-23T20:06:26+00:00","discovered_at":"2026-10-23T20:07:00.262073+00:00","generated_at":"2026-10-23T20:07:03.036680+00:00","sec_items":["3.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Akebia gets Nasdaq deficiency letter as stock closes below $1.00 for 30 straight days","bullets":["Nasdaq Listing Qualifications notified Akebia on October 21, 2026 that its bid price closed under $1.00 for 30 consecutive business days, breaching Rule 5550(a)(2).","Akebia has until April 19, 2027 (180 calendar days) to regain compliance by holding a closing bid of at least $1.00 for 10 straight business days.","If it fails, Akebia could get a second 180-day period by meeting market-value and other initial listing standards and signaling a reverse split if needed.","The notice has no immediate effect on listing; Akebia said it will monitor its bid price and may pursue a reverse stock split, with no assurance of regaining compliance.","CEO John P. Butler signed the filing dated October 23, 2026; continued failure could lead to a Staff delisting determination and appeal to a Nasdaq Hearings Panel."],"urls":{"canonical":"https://secwatch.observer/filing/0001517022-26-000075","json":"https://secwatch.observer/filing/0001517022-26-000075.json","markdown":"https://secwatch.observer/filing/0001517022-26-000075.md","text":"https://secwatch.observer/filing/0001517022-26-000075.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1517022/000151702226000075/0001517022-26-000075-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1517022/000151702226000075/akba-20261021.htm"},"model":{"generated_by":"deepseek-v4.1-flash:cloud@v2","generated_at":"2026-10-23T20:07:03.036680+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}